Business Description
Creative Medical Technology Holdings Inc
NAICS : 325412
SIC : 2834
ISIN : US22529Y1010
Description
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.95 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.49 | |||||
| Beneish M-Score | -2.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -87.2 | |||||
| 3-Year EBITDA Growth Rate | 81.3 | |||||
| 3-Year EPS without NRI Growth Rate | 54.7 | |||||
| 3-Year FCF Growth Rate | 21.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 12.99 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 1519.12 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.94 | |||||
| 9-Day RSI | 58.57 | |||||
| 14-Day RSI | 61.14 | |||||
| 3-1 Month Momentum % | 17.45 | |||||
| 6-1 Month Momentum % | -10.06 | |||||
| 12-1 Month Momentum % | -24.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.13 | |||||
| Quick Ratio | 19.12 | |||||
| Cash Ratio | 18.91 | |||||
| Days Inventory | 511 | |||||
| Days Payable | 29510.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -107.4 | |||||
| Shareholder Yield % | 2.01 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 63.64 | |||||
| Operating Margin % | -51181.82 | |||||
| Net Margin % | -48354.55 | |||||
| FCF Margin % | -47700 | |||||
| ROE % | -58.02 | |||||
| ROA % | -55.72 | |||||
| ROIC % | -1239 | |||||
| 3-Year ROIIC % | 11.35 | |||||
| ROCE % | -60.53 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 673.76 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 1.2 | |||||
| EV-to-EBIT | -0.43 | |||||
| EV-to-EBITDA | -0.44 | |||||
| EV-to-Revenue | 219 | |||||
| EV-to-Forward-Revenue | 23 | |||||
| EV-to-FCF | -0.46 | |||||
| Price-to-GF-Value | 7.35 | |||||
| Price-to-Net-Current-Asset-Value | 1.1 | |||||
| Price-to-Net-Cash | 1.11 | |||||
| Earnings Yield (Greenblatt) % | -232.56 | |||||
| FCF Yield % | -55.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CELZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Creative Medical Technology Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.011 | ||
| EPS (TTM) ($) | -3.8 | ||
| Beta | 1.92 | ||
| 3-Year Sharpe Ratio | -0.22 | ||
| 3-Year Sortino Ratio | -0.36 | ||
| Volatility % | 94.82 | ||
| 14-Day RSI | 61.14 | ||
| 14-Day ATR ($) | 0.665189 | ||
| 20-Day SMA ($) | 4.402 | ||
| 12-1 Month Momentum % | -24.76 | ||
| 52-Week Range ($) | 1.957 - 10.2812 | ||
| Shares Outstanding (Mil) | 1.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Creative Medical Technology Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Creative Medical Technology Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Creative Medical Technology Holdings Inc Frequently Asked Questions
What is Creative Medical Technology Holdings Inc(CELZ)'s stock price today?
The current price of CELZ is $5.39. The 52 week high of CELZ is $10.28 and 52 week low is $1.96.
When is next earnings date of Creative Medical Technology Holdings Inc(CELZ)?
The next earnings date of Creative Medical Technology Holdings Inc(CELZ) is .
Does Creative Medical Technology Holdings Inc(CELZ) pay dividends? If so, how much?
Creative Medical Technology Holdings Inc(CELZ) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers